Accessibility Menu

Enovis(FRA) C520

Market Cap€1.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€21.20
+0.95%
+0.20Today

Enovis Financials at a Glance

Market Cap

€1.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.97K

Net Income (TTM)

-€942.31

EPS (TTM)

-€16.49

P/E Ratio

-1.30

Dividend

€0.00

Beta (Volatility)

0.14 (Low)

Price

€21.20

Volume

0

Open

€21.20

Previous Close

€21.20

Daily Range

€21.20 - €21.20

52-Week Range

€17.40 - €28.40

Estimated Earnings Date

N/A

C520 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Enovis

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Industry

Healthcare Equipment and Supplies

Employees

7,802

CEO

Damien McDonald, MBA

C520 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-54.07%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-76.92%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

57.67M

Volume

0

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Enovis Performance Analysis

Enovis annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,487,287,53423.3%
20232023-12-31EUR 1,579,106,8006.2%
20242024-12-31EUR 1,948,452,44623.4%
20252025-12-31EUR 1,991,930,6412.2%
Enovis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -0.26N/A
20232023-12-31EUR -0.83213.8%
20242024-12-31EUR -13.811567.5%
20252025-12-31EUR -18.3633.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€501.23

+1.0%

Gross Profit

€273.23

+1.1%

Gross Margin

54.51%

+1.1%

Market Cap

€1.23BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.14

N/A

Employees

7,802

N/A

Net Income

-€0.89

+0.0%

EBITDA

€81.45

+1.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.21K

-6.0%

Total Debt

€1.20K

+1.0%

Accounts Receivable

€386.47

+1.0%

Inventory

€526.25

+1.0%

Long Term Debt

€1.14K

+0.9%

Short Term Debt

€54.90

+1.5%

Return on Assets

-24.91%

+1.5%

Return on Invested Capital

-13.46%

N/A

Free Cash Flow

€26.63

+4.4%

Operating Cash Flow

€64.66

+1.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About C520

What is the current price of Enovis?

Enovis is trading at €21.20 per share.

What is the 52-week range for Enovis?

Over the past 52 weeks, Enovis has traded between €17.40 and €28.40.

How much debt does Enovis have?

As of the most recent reporting period, Enovis reported total debt of €1.20B.

How much cash does Enovis have on hand?

Enovis reported €10.99M in cash and cash equivalents in its most recent financial results.

What is Enovis’s dividend yield?

Enovis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.